Green Cross Lab Cell Corporation (144510) — Cash Flow Reinvestment Rate
Green Cross Lab Cell Corporation (144510) has a Cash Flow Reinvestment Rate of 0.30x as of September 2025, reinvesting ₩2.01 Billion (capex ₩624.50 Million plus investments ₩-1.38 Billion) from operating cash flow of ₩6.67 Billion. Explore Green Cross Lab Cell Corporation capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Green Cross Lab Cell Corporation Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for Green Cross Lab Cell Corporation across 9 annual periods. Also explore Green Cross Lab Cell Corporation assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Green Cross Lab Cell Corporation (2015–2024)
Year-by-year capital reinvestment analysis for Green Cross Lab Cell Corporation. For live market cap and broader valuation context, see how much is Green Cross Lab Cell Corporation worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.47x | ₩16.65 Billion | ₩11.34 Billion | ₩6.03 Billion | ▼ -89.8% |
| 2023 | 14.36x | ₩52.70 Billion | ₩3.67 Billion | ₩18.40 Billion | ▲ +2799.7% |
| 2022 | 0.50x | ₩32.88 Billion | ₩66.42 Billion | ₩6.91 Billion | ▼ -60.5% |
| 2021 | 1.25x | ₩29.96 Billion | ₩23.91 Billion | ₩10.88 Billion | ▼ -16.0% |
| 2020 | 1.49x | ₩13.57 Billion | ₩9.09 Billion | ₩4.79 Billion | ▼ -96.1% |
| 2019 | 38.67x | ₩8.62 Billion | ₩223.04 Million | ₩5.34 Billion | ▲ +84.7% |
| 2018 | 20.94x | ₩10.28 Billion | ₩490.92 Million | ₩4.78 Billion | ▲ +47.9% |
| 2017 | 14.16x | ₩40.51 Billion | ₩2.86 Billion | ₩1.78 Billion | ▲ +1115.2% |
| 2015 | 1.17x | ₩1.73 Billion | ₩1.49 Billion | ₩833.86 Million | — |